Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of MK-1167 in participants with Alzheimer's disease dementia; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• MK-1167 (MK-1167)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer Disease, Dementia | Phase 2 | Status: ACTIVE_NOT_RECRUITING